valoctocogene roxaparvovec gene transfer for severe haemophilia a on health-related quality of life
Published 2 years ago • 165 plays • Length 5:08Download video MP4
Download video MP3
Similar videos
-
5:00
valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
-
5:26
seven-year follow-up of valoctocogene roxaparvovec gene therapy for haemophilia
-
3:00
valoctocogene roxaparvovec aav gene therapy for patients with hemophilia a: new results
-
0:57
aav gene transfer for hemophilia
-
3:54
gener8-1 two-year analysis as presented at eahad
-
1:35
improved quality of life in patients with hemophilia a following gene therapy
-
5:39
health-related quality of life in adults with hemophilia b after gene therapy
-
1:45
safety of valoctocogene roxaparvovec for patients with hemophilia a and hiv infection
-
59:12
hemophilia gene therapy: first, do no harm
-
8:57
genetic explanation of how hemophilia inherited
-
1:22:27
new gene therapy for als
-
3:38
gene therapy: an end to hemophilia
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
27:50
a history of hemophilia treatment non replacement therapy to gene therapy
-
4:39
a post hoc analysis of the gener8 1 phase 3 trial
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
18:10
gene therapy for hemophilia
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
2:43
hemophilia a nejm _genetic .therapy
-
1:02:04
multiyear factor viii expression after adeno‐associated virus gene transfer for hemophilia a
-
27:14
isth academy presentation: new treatments in hemophilia
-
0:51
empowering patients with hemophilia to make choices about gene therapy